We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.15%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$216M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$129M |
| 3 |
Brown & Brown
BRO
|
+$121M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
| 5 |
AKRO
Akero Therapeutics
AKRO
|
+$90.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.08% |
| 2 | Technology | 23.91% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Bunge Global
BG
$20.5B
| $8.83M | 0.05% |
109,942
+98,664
| +875% | +$7.77M |
|
452
AutoNation
AN
$7.13B
| $8.82M | 0.05% |
44,423
-22,679
| -34% | -$4.09M |
|
|
ARDT
453
Ardent Health
ARDT
$1.54B
| $8.76M | 0.05% |
641,232
| – | – |
|
454
General Dynamics
GD
$104B
| $8.7M | 0.05% |
+29,828
| New | +$8.21M |
|
455
Neurocrine Biosciences
NBIX
$16.9B
| $8.66M | 0.05% |
68,937
-63,955
| -48% | -$7.33M |
|
456
California Resources
CRC
$4.66B
| $8.64M | 0.05% |
+189,254
| New | +$7.74M |
|
|
KRMN
457
Karman Holdings
KRMN
$7.16B
| $8.6M | 0.05% |
170,779
+210
| +0.1% | +$8.45K |
|
458
Synopsys
SNPS
$77.3B
| $8.57M | 0.05% |
16,725
+12,353
| +283% | +$5.76M |
|
|
ATYR
459
aTyr Pharma
ATYR
$51.9M
| $8.53M | 0.05% |
1,681,595
| – | – |
|
460
Rezolute
RZLT
$479M
| $8.49M | 0.04% |
1,904,131
+875,920
| +85% | +$3.25M |
|
461
Royal Caribbean
RCL
$87.1B
| $8.46M | 0.04% |
27,025
+6,107
| +29% | +$1.45M |
|
462
Equinix
EQIX
$104B
| $8.4M | 0.04% |
10,557
+8,685
| +464% | +$7.37M |
|
463
Moody's
MCO
$83.8B
| $8.39M | 0.04% |
16,736
+3,648
| +28% | +$1.69M |
|
464
O'Reilly Automotive
ORLY
$74.9B
| $8.33M | 0.04% |
92,467
+19,627
| +27% | +$1.79M |
|
465
Williams Companies
WMB
$87.5B
| $8.3M | 0.04% |
132,075
+29,088
| +28% | +$1.72M |
|
466
Cintas
CTAS
$81.5B
| $8.27M | 0.04% |
37,128
+8,149
| +28% | +$1.75M |
|
|
SPR
467
DELISTED
Spirit AeroSystems
SPR
| $8.26M | 0.04% |
216,421
+51,012
| +31% | +$1.83M |
|
|
FARO
468
DELISTED
Faro Technologies
FARO
| $8.08M | 0.04% |
+184,000
| New | +$6.73M |
|
469
Coinbase
COIN
$39.8B
| $8.01M | 0.04% |
+22,866
| New | +$5.35M |
|
470
United Parcel Service
UPS
$92.7B
| $8.01M | 0.04% |
79,366
+69,726
| +723% | +$6.86M |
|
471
Viking Therapeutics
VKTX
$3.84B
| $7.98M | 0.04% |
301,197
+119
| +0% | +$3.13K |
|
472
PNC Financial Services
PNC
$101B
| $7.98M | 0.04% |
42,788
+9,338
| +28% | +$1.58M |
|
473
Replimune Group
REPL
$1B
| $7.95M | 0.04% |
855,988
+750
| +0.1% | +$6.54K |
|
|
AVDL
474
DELISTED
Avadel Pharmaceuticals
AVDL
| $7.94M | 0.04% |
897,086
+225
| +0% | +$1.98K |
|
475
Fortinet
FTNT
$123B
| $7.88M | 0.04% |
74,573
+64,718
| +657% | +$6.53M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q2 2025 Portfolio in Review
As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.
- Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
- Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
- Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
- Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
- Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
- Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
- Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.
Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.